Multicellular modeling of ciliopathy by combining iPS cells and microfluidic airway-on-a-chip technology
Naoyuki Sone, Satoshi Konishi, Koichi Igura, Koji Tamai, Satoshi Ikeo, Y. Korogi, Shuhei Kanagaki, T. Namba, Yuki Yamamoto, Yifei Xu, Kazuhiko Takeuchi, Yuichi Adachi, Toyofumi F. Chen‐Yoshikawa, Hiroshi Date, Masatoshi Hagiwara, Sachiko Tsukita, Toyohiro Hirai, Yu‐suke Torisawa, Shimpei Gotoh
Abstract
Mucociliary clearance is an essential lung function that facilitates the removal of inhaled pathogens and foreign matter unidirectionally from the airway tract and is innately achieved by coordinated ciliary beating of multiciliated cells. Should ciliary function become disturbed, mucus can accumulate in the airway causing subsequent obstruction and potentially recurrent pneumonia. However, it has been difficult to recapitulate unidirectional mucociliary flow using human-derived induced pluripotent stem cells (iPSCs) in vitro and the mechanism governing the flow has not yet been elucidated, hampering the proper humanized airway disease modeling. Here, we combine human iPSCs and airway-on-a-chip technology, to demonstrate the effectiveness of fluid shear stress (FSS) for regulating the global axis of multicellular planar cell polarity (PCP), as well as inducing ciliogenesis, thereby contributing to quantifiable unidirectional mucociliary flow. Furthermore, we applied the findings to disease modeling of primary ciliary dyskinesia (PCD), a genetic disease characterized by impaired mucociliary clearance. The application of an airway cell sheet derived from patient-derived iPSCs and their gene-edited counterparts, as well as genetic knockout iPSCs of PCD causative genes, made it possible to recapitulate the abnormal ciliary functions in organized PCP using the airway-on-a-chip. These findings suggest that the disease model of PCD developed here is a potential platform for making diagnoses and identifying therapeutic targets and that airway reconstruction therapy using mechanical stress to regulate PCP might have therapeutic value.